"Signature GYN Services is research facility specializing in phase II-IV clinical trials in women’s healthcare. As part of a full-time gynecology practice in a large urban metroplex, we are accessible to a large population base. We treat a variety of gynecological problems including endometriosis, uterine fibroids, menopausal symptoms, STD testing, and provide contraceptive services on a daily basis."

During the past decade, Signature GYN Services, PLLC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Signature GYN Services, PLLC" #1 sponsor was "Bayer" with 2 trials, followed by "Curatek Pharmaceuticals, LLC" with 1 trials sponsored, "Estetra" with 1 trials sponsored, "Insud Pharma" with 1 trials sponsored and "Kissei Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Signature GYN Services, PLLC" #1 collaborator was "Chemo Research" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Signature GYN Services, PLLC" are "Endometriosis" (2 trials), "Bone Loss" (1 trials), "Candida Vulvovaginitis" (1 trials), "Change in Bone Mineral Density" (1 trials) and "Hot Flashes" (1 trials). Many other conditions were trialed in "Signature GYN Services, PLLC" in a lesser frequency.

Most popular intervention types in "Signature GYN Services, PLLC" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials), "Placebo" (2 trials) and "Placebo capsule to match Add-back capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Signature GYN Services, PLLC" are 8 trials for "Female" genders.

Currently, there are NaN active trials in "Signature GYN Services, PLLC". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Signature GYN Services, PLLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Signature GYN Services, PLLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".